Replies to post #4371 on IGC Pharma, Inc. (IGC)

[ANTI-BAGHOLDER]

Revenue - Total revenue was about $2.27 million for the year ended March 31, 2014, as compared to about $8.03 million for the year ended March 31, 2013, a decrease of 71.69%. The revenue reported for 2014 and 2013 is from trading of iron ore in China, construction and equipment rental in India. The majority of the decrease in revenue year over year is from the decreased volume of trading. For fiscal 2014, about $2.20 million is from trading of iron ore in China as compared to about $7.2 million of trading revenue for fiscal 2013. The decrease in trading revenue is to a large extent from a decrease in the volume of trading and to a lesser extent from a decrease in the sales price. The Company chose to divert financial resources temporarily away from trading and construction to new initiatives. Based on the new initiatives, we anticipate revenue increasing to the levels of 2013 in fiscal 2015.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10096130

WOW! This company is a dog. Revenue down 71% since last year. And off to a horrible start this fiscal year. More dilution coming.